Quarterly report · Q3
4360.TEDINET S100SO8N
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.9bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥11.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.7bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | −¥142m | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥819m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | −¥70m | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥991m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | −¥20m | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥3m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥821m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥809m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥0 | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥809m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥14.3bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥15.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥15.5bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.1bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥11.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥11.0bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-0.4 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.05 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥103.26 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.9 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.49 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 77.4% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥2.5bn |
| jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥2.5bn |
| jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥359m |
| jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥3.4bn |
| jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥3.4bn |
| jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥300m |
| jpcrp040300-q3r_E36769-000Health Support Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.0bn |
| jpcrp040300-q3r_E36769-000Health Support Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥1.0bn |
| jpcrp040300-q3r_E36769-000Health Support Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥46m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥6.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥6.9bn |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥706m |
| jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E36769-000Fine Chemical Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥443m |
| jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.7bn |
| jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.7bn |
| jpcrp040300-q3r_E36769-000Flame Retardants Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E36769-000Health Support Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥940m |
| jpcrp040300-q3r_E36769-000Health Support Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥940m |
| jpcrp040300-q3r_E36769-000Health Support Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥17m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥8.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥8.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥1.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 332
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss | Prior1YTDDuration | 809000000 | JPY |
| Profit loss | CurrentYTDDuration | -0 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -34000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 80000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | 0 | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | -0 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | -2000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 3000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -36000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 83000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 773000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 82000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 773000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 80000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 2000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E36769-000FineChemicalBusinessReportableSegmentsMember | 3050000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 4666000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E36769-000HealthSupportBusinessReportableSegmentsMember | 940000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 8657000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E36769-000FineChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E36769-000HealthSupportBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E36769-000FineChemicalBusinessReportableSegmentsMember | 3050000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 4666000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E36769-000HealthSupportBusinessReportableSegmentsMember | 940000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 8657000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E36769-000FineChemicalBusinessReportableSegmentsMember | 443000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 1102000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E36769-000HealthSupportBusinessReportableSegmentsMember | 17000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1563000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E36769-000FineChemicalBusinessReportableSegmentsMember | 2462000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 3427000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E36769-000HealthSupportBusinessReportableSegmentsMember | 1048000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 6937000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E36769-000FineChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E36769-000HealthSupportBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E36769-000FineChemicalBusinessReportableSegmentsMember | 2462000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 3427000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E36769-000HealthSupportBusinessReportableSegmentsMember | 1048000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 6937000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E36769-000FineChemicalBusinessReportableSegmentsMember | 359000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 300000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E36769-000HealthSupportBusinessReportableSegmentsMember | 46000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 706000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |